Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genitourinary lymphomas].

P Brice1, E de Kerviler

  • 1Hôpital Saint-Louis, Claude-Vellefaux, Paris, France. pauline.brice@sls.ap-hop-paris.fr

Annales D'Urologie
|March 7, 2007
PubMed
Summary
This summary is machine-generated.

Genitourinary tract lymphomas are rare, necessitating accurate diagnosis for specific treatment. Immunohistochemical diagnosis and staging are key for tailoring chemotherapy and immunotherapy options based on prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Hematological oncology·2024
Same author

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.

British journal of haematology·2023
Same author

Prognostic value of PET/CT and CT in T-cell lymphoblastic lymphoma/leukaemia patients: A retrospective cohort study of 145 patients.

British journal of haematology·2023
Same author

Salvage Percutaneous Cryoablation for Bleeding Upper Tract Urothelial Carcinoma.

Cardiovascular and interventional radiology·2022
Same author

Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2021
Same author

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma.

Annals of hematology·2021
Same journal

Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.

Annales d'urologie·2008
Same journal

[Surgical treatment of ureteropyelic junction stenosis using robotic-assisted laparoscopy].

Annales d'urologie·2008
Same journal

[Robotic-assisted laparoscopy: general principles].

Annales d'urologie·2008
Same journal

[De novo tumours of renal transplants].

Annales d'urologie·2008
Same journal

[Immunosuppression in kidney transplantation].

Annales d'urologie·2008
Same journal

[Surgical complications in kidney transplantation].

Annales d'urologie·2008
See all related articles

Area of Science:

  • Oncology
  • Pathology

Context:

  • Lymphomas of the genitourinary tract are uncommon neoplasms.
  • Kidney and testis are the most frequent sites affected.
  • Accurate diagnosis and staging are critical for treatment planning.

Purpose:

  • To highlight the importance of precise diagnosis in genitourinary lymphomas.
  • To outline the diagnostic challenges and therapeutic strategies.

Summary:

  • Genitourinary lymphomas require specific immunohistochemical diagnosis and staging.
  • Treatment primarily involves chemotherapy, with immunotherapy for B-cell lymphomas.
  • Treatment intensity and duration are guided by prognostic factors.

Impact:

  • Improved diagnostic accuracy can lead to more effective, personalized treatment strategies.

Related Experiment Videos

  • Better staging enhances the selection of appropriate therapeutic options.
  • Understanding prognostic factors aids in optimizing chemotherapy and immunotherapy regimens for better patient outcomes.